Velos 17,5 mg Injektionsvätska, lösning i förfylld spruta

Country: Sweden

Bahasa: Sweden

Sumber: Läkemedelsverket (Medical Products Agency)

Ciri produk Ciri produk (SPC)
22-04-2018

Bahan aktif:

metotrexat

Boleh didapati daripada:

Difa Cooper S.p.A.

Kod ATC:

L04AX03

INN (Nama Antarabangsa):

methotrexate

Dos:

17,5 mg

Borang farmaseutikal:

Injektionsvätska, lösning i förfylld spruta

Komposisi:

metotrexat 17,5 mg Aktiv substans

Kelas:

Apotek

Jenis preskripsi:

Receptbelagt

Kawasan terapeutik:

Metotrexat

Ringkasan produk:

Förpacknings: Förfylld spruta, 4 x 1 st (med fast injektionsnål) (med automatiskt nålskydd och spritsudd); Förfylld spruta, 1 st (med fast injektionsnål) (med automatiskt nålskydd och spritsudd); Förfylld spruta, 1 st (med fast injektionsnål) (med automatiskt nålskydd); Förfylld spruta, 1 st (med fast injektionsnål) (med spritsudd); Förfylld spruta, 1 st (med fast injektionsnål); Förfylld spruta, 4 x 1 st (med fast injektionsnål) (med automatiskt nålskydd); Förfylld spruta, 4 x 1 st (med fast injektionsnål) (med spritsudd); Förfylld spruta, 4 x 1 st (med fast injektionsnål)

Status kebenaran:

Avregistrerad

Tarikh kebenaran:

2015-10-02

Ciri produk

                                1
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Velos 2.5 mg solution for injection in pre-filled syringe
Velos 7.5 mg solution for injection in pre-filled syringe
Velos 10 mg solution for injection in pre-filled syringe
Velos 12.5 mg solution for injection in pre-filled syringe
Velos 15 mg solution for injection in pre-filled syringe
Velos 17.5 mg solution for injection in pre-filled syringe
Velos 20 mg solution for injection in pre-filled syringe
Velos 22.5 mg solution for injection in pre-filled syringe
Velos 25 mg solution for injection in pre-filled syringe
Velos 27.5 mg solution for injection in pre-filled syringe
Velos 30 mg solution for injection in pre-filled syringe
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
_Velos 2.5 mg:_
Each pre-filled syringe of 0.33 ml contains 2.5 mg methotrexate.
_Velos 7.5 mg:_
Each pre-filled syringe of 0.30 ml contains 7.5 mg methotrexate.
_Velos 10 mg: _
Each pre-filled syringe of 0.40 ml contains 10 mg methotrexate.
_ _
_Velos 12.5 mg: _
Each pre-filled syringe of 0.31 ml contains 12.5 mg methotrexate.
_Velos 15 mg: _
Each pre-filled syringe of 0.38 ml contains 15 mg methotrexate.
_Velos 17.5 mg: _
Each pre-filled syringe of 0.44 ml contains 17.5 mg methotrexate.
_Velos 20 mg: _
Each pre-filled syringe of 0.50 ml contains 20 mg methotrexate.
_Velos 22.5 mg: _
Each pre-filled syringe of 0.56 ml contains 22.5 mg methotrexate.
_Velos 25 mg: _
Each pre-filled syringe of 0.63 ml contains 25 mg methotrexate.
_Velos 27.5 mg: _
Each pre-filled syringe of 0.69 ml contains 27.5 mg methotrexate.
_Velos 30 mg: _
Each pre-filled syringe of 0.75 ml contains 30 mg methotrexate.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection in pre-filled syringe (solution for injection).
Clear, yellowish-orange solution free from visible particles.
Osmolality: 280 – 320 mOsm/kg.
pH: 7.0 – 9.0.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Velos is indicated for the treatment of
-
active rheumatoid arthritis in adult patients
                                
                                Baca dokumen lengkap
                                
                            

Dokumen dalam bahasa lain

Risalah maklumat Risalah maklumat Inggeris 07-10-2020
Ciri produk Ciri produk Inggeris 07-10-2020
Laporan Penilaian Awam Laporan Penilaian Awam Inggeris 02-10-2015